Evgen Pharma plc (EVG.L) LSE
Currency In GBp
- General
- Statistics
- Historical Data
- Profile
- Financials
Evgen Pharma plc
Address
Alderley Park, Block 24
Nether Alderley, SK10 4TG
United Kingdom of Great Britain and Northern Ireland (the)
Phone
44 16 2546 6591
Website
Sector
Healthcare
Industry
Biotechnology
Employees
10
First IPO Date
October 21, 2015
Key Executives
| Name | Title | Pay | Year Born |
| Huw Jones | Chief Executive Officer & Executive Director | 304,730 | 1959 |
| Glen Clack | Chief Medical Officer | 0 | N/A |
| Helen Kuhlman | Chief Business Officer | 0 | N/A |
| Toni Haenninen | Chief Financial Officer & Director | 0 | 1977 |
Description
Evgen Pharma plc, a UK-based pharmaceutical company founded in 2014, operates at the clinical development stage, concentrating on the creation of sulforaphane-based medications. Its mission is to combat various cancers and inflammatory conditions. The firm utilizes its proprietary Sulforadex technology, which is engineered to stabilize sulforaphane, in its product development. SFX-01 stands as their principal drug candidate, currently in Phase II clinical trials for metastatic breast cancer and Phase Ib/IIa trials for glioblastoma. Furthermore, SFX-01 is being investigated in preclinical stages for haematological malignancies and analogous disorders. The company also offers out-licensing services for its innovative technology.
